Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News ESC 2024

AI Tool Doesn’t Increase Appropriate Referrals to Angiography, but Might Help Some

Yael L. Maxwell

September 06, 2024

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

L.A. McKeown

June 03, 2021

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Presentation

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

November 14, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

News Daily News

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Todd Neale

February 03, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Daily News

Stress CMR for CAD Matches Prognostic Utility of More Established Techniques

L.A. McKeown

June 03, 2013

Advertisement

AI Tool Doesn’t Increase Appropriate Referrals to Angiography, but Might Help Some

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Stress CMR for CAD Matches Prognostic Utility of More Established Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content